Spectrum Pharma Inc (SPPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,189 | -69,770 | -52,642 | -45,719 | -62,134 |
| Depreciation Amortization | 33,429 | 32,898 | 37,781 | 30,769 | 9,840 |
| Income taxes - deferred | -5,237 | -104 | N/A | 1,724 | 33,252 |
| Accounts receivable | 11,357 | -2,599 | 33,228 | -19,601 | 42,686 |
| Other Working Capital | 14,310 | -17,796 | 1,337 | -14,961 | 7,672 |
| Other Operating Activity | -525 | 16,912 | -12,960 | 44,161 | -33,402 |
| Operating Cash Flow | $-38,855 | $-40,459 | $6,744 | $-3,627 | $-2,086 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -15 | N/A | N/A | N/A | N/A |
| PPE Investments | -465 | -78 | -223 | -934 | -161 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -14,169 |
| Purchase Of Investment | N/A | N/A | 3,061 | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 4,093 | N/A |
| Other Investing Activity | -601 | -601 | 0 | -25,000 | 0 |
| Investing Cash Flow | $-1,081 | $-679 | $2,838 | $-21,841 | $-14,330 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 7,000 |
| Debt Issued | -27,500 | N/A | N/A | N/A | 220,000 |
| Debt Repayment | N/A | -9,014 | N/A | N/A | -175,000 |
| Common Stock Issued | 130,428 | 73,343 | 2,109 | 2,545 | 15,174 |
| Common Stock Repurchased | -27,189 | 21 | -638 | -1,733 | -27,343 |
| Dividend Paid | N/A | -6 | N/A | N/A | N/A |
| Other Financing Activity | 32,982 | -4,700 | 0 | 0 | -4,573 |
| Financing Cash Flow | $108,721 | $59,644 | $1,471 | $812 | $35,258 |
| Exchange Rate Effect | 316 | -25 | -1,254 | -1,708 | -2,235 |
| Beginning Cash Position | 158,222 | 139,741 | 129,942 | 156,306 | 139,698 |
| End Cash Position | 227,323 | 158,222 | 139,741 | 129,942 | 156,306 |
| Net Cash Flow | $69,101 | $18,481 | $9,799 | $-26,364 | $16,608 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,855 | -40,459 | 6,744 | -3,627 | -2,086 |
| Capital Expenditure | -465 | -78 | -223 | -934 | -161 |
| Free Cash Flow | -39,320 | -40,537 | 6,521 | -4,561 | -2,247 |